# Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain

> **NCT06810245** · PHASE1 · COMPLETED · sponsor: **Contineum Therapeutics** · enrollment: 43 (actual)

## Conditions studied

- Chronic Osteoarthritis Pain
- Chronic Low Back Pain

## Interventions

- **DRUG:** PIPE-791
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06810245
- **Lead sponsor:** Contineum Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-04
- **Primary completion:** 2026-01-20
- **Final completion:** 2026-01-20
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06810245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06810245, "Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06810245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
